EPOPROSTENOL TEVA ® 0.5 MG

Land: Israel

Sprache: Englisch

Quelle: Ministry of Health

Wirkstoff:

EPOPROSTENOL AS SODIUM 0.5 MG

Verfügbar ab:

SALOMON,LEVIN & ELSTEIN LTD

ATC-Code:

B01AC09

Darreichungsform:

POWDER AND SOLVENT FOR SOLUTION FOR INFUSION

Verabreichungsweg:

I.V

Hergestellt von:

TEVA PARENTERAL MEDICINES INC, USA

Therapiegruppe:

EPOPROSTENOL

Anwendungsgebiete:

Epoprostenol Teva is indicated for the long-term intravenous treatment of primary arterial pulmonary hypertension and arterial pulmonary hypertension associated with the scleroderma spectrum of disease in NYHA class III and class IV patients who do not respond to conventional therapy.

Berechtigungsdatum:

2009-11-01